ESAB lifts 2026 sales and EBITDA targets after record Q2, but trims EPS view

summarizeSummary

Record Q2 sales of $808M prompted ESAB to raise its full-year sales and EBITDA outlook, but EPS guidance fell on acquisition-related costs and higher interest expense.

check_boxKey Events · Earnings and Guidance · ESAB

• Record Q2 Sales, Organic Growth Returns

  Sales reached a record $808 million in Q2, a 12.9% reported increase, with core organic growth of 2.5% driven by gains in both the Americas and EMEA/APAC segments.

• Eddyfi Acquisition Closed Early

  The $1.45 billion Eddyfi Technologies acquisition closed one month ahead of schedule, adding approximately 9% to the full-year sales growth guidance.

• Full-Year Sales and EBITDA Guidance Raised

  The 2026 total core sales growth outlook was raised to 11.0%–14.0% from 6.0%–9.0%, and the core adjusted EBITDA forecast increased to $615M–$625M from $575M–$595M.

• EPS Guidance Cut on Higher Costs

  Core adjusted EPS guidance was lowered to $5.40–$5.50 from $5.70–$5.90, reflecting higher interest expense, integration costs, and transitory price/cost headwinds.

auto_awesomeAnalysis · ESAB · Technology

Record Q2 sales of $808 million—up 12.9% on a reported basis—were powered by 2.5% core organic growth across both segments. The Eddyfi acquisition closed ahead of schedule, fueling a sharp upward revision to full-year sales and EBITDA guidance. Yet the bottom-line picture dimmed: core adjusted EPS guidance was cut to $5.40–$5.50 from $5.70–$5.90, as higher interest costs and integration expenses bite. This split narrative—strong top-line momentum colliding with lower profit expectations—will likely stir near-term stock volatility while investors weigh the Eddyfi deal's benefits against immediate margin pressure.